Risks for Staphylococcus aureus colonization in patients with psoriasis: a systematic review and meta-analysis

British Journal of Dermatology

Volumn 177, Issue 4, 2017, Pages 967-977

  Ng, C Y ^a,b,c   Huang, Y H ^a,b   Chu, C F ^b   Wu, T C ^b   Liu, S H ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATOPY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; ADOLESCENT; ADULT; AGED; CHILD; COMPLICATION; EPIDEMIOLOGY; FEMALE; INFANT; MALE; META ANALYSIS; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS INFECTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PSORIASIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 85028940825     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15366     Document Type: Review

References (53)

1. Parisi R, Symmons DP, Griffiths CE et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133:377–85.
2. Biedermann T, Skabytska Y, Kaesler S et al. Regulation of T cell immunity in atopic dermatitis by microbes: the yin and yang of cutaneous inflammation. Front Immunol 2015; 6:353.
3. Leung DY, Bhan AK, Schneeberger EE et al. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983; 71:47–56.
4. Yarwood JM, Leung DY, Schlievert PM. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol Lett 2000; 192:1–7.
5. El Ferezli J, Jenbazian L, Rubeiz N et al. Streptococcus sp. and Staphylococcus aureus isolates from patients with psoriasis possess genes that code for toxins (superantigens): clinical and therapeutic implications. Immunopharmacol Immunotoxicol 2008; 30:195–205.
6. Balci DD, Duran N, Ozer B et al. High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis. Eur J Dermatol 2009; 19:238–42.
7. Casas C, Ribet V, Alvarez-Georges S et al. Modulation of interleukin-8 and staphylococcal flora by Avene hydrotherapy in patients suffering from chronic inflammatory dermatoses. J Eur Acad Dermatol Venereol 2011; 25 (Suppl. 1):S19–23.
8. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol 2011; 9:244–53.
9. Menter A, Korman NJ, Elmets CA et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011; 65:137–74.
10. Liu SH, Hsieh TH, Chen LY et al. Biologics-associated risks for incident skin and soft tissue infections in psoriasis patients: results from propensity score-stratified survival analysis. Available at: http://biorxiv.org/content/early/2017/04/17/126383 (last accessed 28 June 2017).
11. Noble WC. Staphylococcus aureus on the hair. J Clin Pathol 1966; 19:570–2.
12. Aly R, Maibach HE, Mandel A. Bacterial flora in psoriasis. Br J Dermatol 1976; 95:603–6.
13. Nguyen V, Huggins RH, Lertsburapa T et al. Cutaneous T-cell lymphoma and Staphylococcus aureus colonization. J Am Acad Dermatol 2008; 59:949–52.
14. Graber CJ, Shane AL, Weintrub P et al. Clonality of Staphylococcus aureus colonization over time in attendees of a camp for children with chronic dermatoses. Pediatr Dermatol 2011; 28:519–23.
15. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339:b2535.
16. Wells GA, Shea B, O'Donnell D et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonradomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (last accessed 28 June 2017).
17. Whiting PF, Rutjes AW, Westwood ME et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155:529–36.
18. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health 2014; 72:39.
19. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557–60.
20. Davies HTO, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ 1998; 316:989–91.
21. Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2005; 25:3443–57.
22. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Technical Bulletin 1999; 47:15–7.
23. StataCorp. 2013. Stata statistical software: release 13. College Station, TX: StataCorp LP.
24. Marcus E, Demmler D, Rudolph A et al. Bacterial colonization of psoriasis plaques. Is it relevant? Dermatol Rep 2011; 3:e14.
25. Marples RR, Heaton CL, Kligman AM. Staphylococcus aureus in psoriasis. Arch Dermatol 1973; 107:568–70.
26. Leyden JJ, Kligman AM. The role of microorganisms in diaper dermatitis. Arch Dermatol 1978; 114:56–9.
27. Weissmann A, Noble WC. Photochemotherapy of psoriasis: effects on bacteria and surface lipids in uninvolved skin. Br J Dermatol 1980; 102:185–93.
28. Atefi N, Tabaie M, Noorbakhsh S et al. The role of staphylococcus superantigens in chronic plaque type psoriasis. Iran J Dermatol 2012; 15:1–3.
29. Sayama K, Midorikawa K, Hanakawa Y et al. Superantigen production by Staphylococcus aureus in psoriasis. Dermatology 1998; 196:194–8.
30. Flytström I, Bergbrant IM, Bråred J et al. Microorganisms in intertriginous psoriasis: no evidence of Candida. Acta Derm Venereol 2003; 83:121–3.
31. Tomi NS, Kranke B, Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J Am Acad Dermatol 2005; 53:67–72.
32. Reich-Schupke S, Geis G, Reising M et al. MRSA in dermatology – prospective epidemiological study in employees and patients of a dermatological department of a university hospital. J Dtsch Dermatol Ges 2010; 8:607–12.
33. Varley C, Deodhar AA, Ehst B et al. Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy. Rheumatology (Oxford) 2014; 53:332–7.
34. Klein PA, Greene WH, Fuhrer J et al. Prevalence of methicillin-resistant Staphylococcus aureus in outpatients with psoriasis, atopic dermatitis, or HIV infection. Arch Dermatol 1997; 133:1463–5.
35. Leung DY, Walsh P, Giorno R et al. A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 1993; 100:225–8.
36. Andersen PS, Larsen LA, Fowler VG Jr et al. Risk factors for Staphylococcus aureus nasal colonization in Danish middle-aged and elderly twins. Eur J Clin Microbiol Infect Dis 2013; 32:1321–6.
37. Brook I. Secondary bacterial infections complicating skin lesions. J Med Microbiol 2002; 51:808–12.
38. Nestle FO, Di Meglio P, Qin JZ et al. Skin immune sentinels in health and disease. Nat Rev Immunol 2009; 9:679–91.
39. Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 2011; 11:505–18.
40. Nakatsuji T, Gallo RL. Antimicrobial peptides: old molecules with new ideas. J Invest Dermatol 2012; 132:887–95.
41. Brown AF, Leech JM, Rogers TR et al. Staphylococcus aureus colonization: modulation of host immune response and impact on human vaccine design. Front Immunol 2014; 4:507.
42. + T cells in psoriatic lesions preferentially use T-cell receptor Vβ3 and/or Vβ13.1 genes. Proc Natl Acad Sci U S A 1994; 91:9282–6.
43. Lewis HM, Baker BS, Bokth S et al. Restricted T-cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 1993; 129:514–20.
44. Gao Z, Tseng CH, Strober BE et al. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLOS ONE 2008; 3:e2719.
45. Alekseyenko AV, Perez-Perez GI, De Souza A et al. Community differentiation of the cutaneous microbiota in psoriasis. Microbiome 2013; 1:31.
46. Fahlen A, Engstrand L, Baker BS et al. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res 2012; 304:15–22.
47. Kong HH, Andersson B, Clavel T et al. Performing skin microbiome research: a method to the madness. J Invest Dermatol 2017; 137:561–8.
48. Totte JE, van der Feltz WT, Hennekam M et al. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol 2016; 175:687–95.
49. Schlievert PM, Strandberg KL, Lin YC et al. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 2010; 125:39–49.
50. Chuang YY, Huang YC. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis 2013; 13:698–708.
51. Wertheim HFL, Melles DC, Vos MC et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5:751–62.
52. Grice EA, Kong HH, Conlan S et al. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324:1190–2.
53. Noble WC, Savin JA. Carriage of Staphylococcus aureus in psoriasis. BMJ 1968; 1:417–8.